Gland Pharma shines on reporting jumps 97% in Q4 consolidated net profit
Gland Pharma is currently trading at Rs. 2138.55, up by 271.45 points or 14.54% from its previous closing of Rs. 1867.10 on the BSE.
The scrip opened at Rs. 2170.00 and has touched a high and low of Rs. 2170.00 and Rs. 2031.00 respectively. So far 264103 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2170.00 on 18-May-2025 and a 52 week low of Rs. 1453.00 on 19-May-2025.
Last one week high and low of the scrip stood at Rs. 2,170.00 and Rs. 1812.45 respectively. The current market cap of the company is Rs. 35182.09 crore.
The promoters holding in the company stood at 51.83%, while Institutions and Non-Institutions held 40.65% and 7.52% respectively.
Gland Pharma has reported 44.99% rise in its net profit at Rs 420.45 crore for the fourth quarter ended March 31, 2026 (Q4FY26) as compared to Rs 289.99 crore for the same quarter in the previous year. The total income of the company has increased by 27.36% at Rs 1,367.95 crore for Q4FY26 as compared to Rs 1,074.07 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 96.57% jump in its net profit at Rs 366.68 crore for the fourth quarter ended March 31, 2026 as compared to Rs 186.54 crore for the same quarter in the previous year. The total income of the company increased by 26.23% at Rs 1,854.26 crore for Q4FY26 as compared to Rs 1,468.94 crore for the corresponding quarter previous year.
For the year ended March 31, 2026, the company has reported 19.25% rise in its net profit at Rs 1,299.55 crore as compared to Rs 1,089.75 crore for the previous year. The total income of the company has increased by 12.12% at Rs 4,855.99 crore for year under review as compared to Rs 4,331.22 crore for year ended March 31, 2025.
